Our Senior Advisors

Dr Duncan Moore

Former Global Head of Healthcare Research at Morgan Stanley, Dr. Moore is now a private investor and serves on the boards of Forward Pharma A/S, Cycle Pharmaceuticals, ASP Isotopes Inc., and GH Research PLC. He has an M.Phil. and Ph.D. from the University of Cambridge where he was also a post-doctoral research fellow.

F. Samuel Eberts III

Former Chief Legal Officer, Corporate Secretary and Senior Vice President of Corporate Affairs for LabCorp (NYSE: LH), Dr Eberts is now CEO of Daerter Group, and a director at DIH Technology Co. (NASDAQ: DHAI), Philipps Companies Ltd, and a Senior Lecturing Fellow, at Duke University.

Dr Richard Christie

Former Global Head of Development Science & Innovation and Head of the External Development Group at Roche, and Former Vice President of External Research and Early Development at Johnson & Johnson. Dr Christie holds an MD and PhD in Neurobiology and Medicine from Harvard Medical School.

Dr Michelle Tempest 

Dr. Michelle Tempest is Senior Partner at Candesic She advises institutional investors and healthcare providers globally, leveraging her expertise in market strategy, innovation, and digital health. She is the author of Big Brain Revolution, serves on the Digital Health Council of the Royal Society of Medicine, and holds degrees in Medicine from the University of Cambridge.

Aris Kekedjan

Partner

Former Chief Investment Officer at General Electric (NYSE: GE) and CEO at Trinity Life Sciences, and previously CEO at Carl Icahn Holdings (NASDAQ: IEP)

Donald Ewer

Partner

Former Portfolio Manager with experience across a range of asset classes and situations in world-leading investmetn firms and hedge funds

Julien Nicod

Partner

Founder of Alts and Alts Club, a membership-based LP investor network. Seasoned Entrepreneur and Investor across a range of asset classes, sectors and geographies.

Our Investment Team

Dr Elad I. Ely MD MBA FACS FAHA

Elad I. Levy is Professor of Neurosurgery and Radiology and Chair of Neurological Surgery at the Jacobs School of Medicine, SUNY Buffalo. He has co-authored over 500 peer-reviewed publications, served on the CNS Executive Committee since 2007, and is a past president of the CNS Foundation, where he helped launch global philanthropic initiatives. He currently serves as Vice Chair of the American Board of Neurological Surgery and Endovascular Section Editor for Neurosurgery. Dr. Levy is internationally recognized for his leadership in advancing neurovascular care, education, and innovation.

Dr Vadim Pinskiy

Dr. Vadim Pinskiy is a neuroscientist and technology leader with deep expertise in biomedical engineering, data science, and translational research. He has led cross-functional teams in the development of advanced imaging technologies, data platforms, and AI-driven tools for neuroscience. Dr. Pinskiy has published extensively in the fields of neuroimaging and computational biology and has overseen large-scale research programs spanning academia and industry.

Dr Aimee DeGaetano, MPH, RD

Aimee de Gaetano is a leading expert in neurological innovation, clinical strategy, and global medical affairs, with a background spanning clinical research, digital health, and technology development. She has authored over 500 abstracts and clinical manuscripts and has led multi-institutional initiatives focused on patient-centered care and translational research. Aimee has also served in advisory roles across academia, industry, and nonprofit sectors, shaping global strategies in neurology and neurotechnology.

Our Venture Partners

Our Syndicate Deal Leaders

Yizhen Dong

Former Healthcare & Life Sciences Growth Equity Leader at Koch Disruptive Technologies, former Partner at Global Founders Capital, and was earlier a Principal at 11.2 Capital, working in the frontier of computational biology and synthetic biology. Yizhen holds an MBA (full-tuition scholar) from The University of Chicago Booth School of Business, a Master’s in Computational Biology from the University of Maryland, and a BA in Economics from Vanderbilt University.

Thanighan Kirupananthan

Thanighan worked with several prominent family offices, including Apeiron Investment Group, where he focused on healthcare growth-stage private equity coverage across a platform with $4.5 billion AUM. He previously served as an analyst at Deutsche Bank and began his career as a medical doctor within the NHS. He holds a Doctor of Medicine (MD) and Bachelor of Medicine, Bachelor of Surgery (MBBS) from Imperial College London.

Christian Repole

Christian is Chief of Staff at a division of Woodbridge, one of the world’s largest single-family offices. He was previously an Engagement Manager at McKinsey & Company, with experience in Private Equity, M&A, Tech roll-ups, and platform development, and holds deep expertise in value creation for data-centric businesses. Christian graduated with First-Class Honors BA and Masters in Engineering (MEng) from the University of Cambridge.

Our Advisory Team Leaders

Ruwani Hettiarachchi

Ruwani is an Entrepreneurial M&A professional with over 20 years experience  intersection of Strategy and Transactions, across the deal cycles. She was Chief Growth Officer and previously Director of Strategy at Hemas Holdings PLC and has previously served on the boards of Colombo Academy of Hospitality Management (William Angliss) at SLIIT and Digital Healthcare Solutions (Pvt) Ltd. She is a Sloan Fellow (with Distinction) from the London Business School and holds a Master’s in Economics from the University of Edinburgh.

To be announced

Partner

To be announced

Partner